Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.
about
Redefining short bowel syndrome in the 21st century.Pathophysiology, prevention, treatment, and outcomes of intestinal failure-associated liver disease.Nutritional therapy complications in children with ultra-short bowel syndrome include growth deficiency but not cholestasis.Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis.Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis
P2860
Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lipid emulsions in the treatme ...... sease in infants and children.
@en
type
label
Lipid emulsions in the treatme ...... sease in infants and children.
@en
prefLabel
Lipid emulsions in the treatme ...... sease in infants and children.
@en
P2093
P2860
P356
P1476
Lipid emulsions in the treatme ...... sease in infants and children.
@en
P2093
Gillian L Fell
Kathleen M Gura
Mark Puder
Prathima Nandivada
P2860
P304
P356
10.3945/AJCN.114.103986
P407
P577
2016-01-20T00:00:00Z